Literature DB >> 8467473

Trisomy 14 in hematologic diseases. Another non-random abnormality within myeloid proliferative disorders.

M Mancini1, M Cedrone, M Nanni, M B Rondinelli, M C Petti, M R De Cuia, G Alimena.   

Abstract

Two cases of myelodysplastic syndrome (MDS) and a case of acute nonlymphoblastic leukemia (ANLL) with a trisomy 14 are presented. The series of results derived from our cases, and those previously reported, strongly suggest that this anomaly may be another nonrandom change, confined within myeloid disorders and associated with patients' advanced age, marked tendency to bone marrow dysplastic features, normal platelet values, and not unfavorable prognosis.

Entities:  

Mesh：

Year:  1993        PMID： 8467473     DOI： 10.1016/0165-4608(93)90146-d

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


  4 in total

Review 1.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

2.  Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.

Authors:  Joseph Saliba; Cécile Saint-Martin; Antonio Di Stefano; Gaëlle Lenglet; Caroline Marty; Boris Keren; Florence Pasquier; Véronique Della Valle; Lise Secardin; Gwendoline Leroy; Emna Mahfoudhi; Sarah Grosjean; Nathalie Droin; M'boyba Diop; Philippe Dessen; Sabine Charrier; Alberta Palazzo; Jane Merlevede; Jean-Côme Meniane; Christine Delaunay-Darivon; Pascal Fuseau; Françoise Isnard; Nicole Casadevall; Eric Solary; Najet Debili; Olivier A Bernard; Hana Raslova; Albert Najman; William Vainchenker; Christine Bellanné-Chantelot; Isabelle Plo
Journal:  Nat Genet       Date:  2015-08-17       Impact factor: 38.330

3.  Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression.

Authors:  Wei Cui; Carlos E Bueso-Ramos; C Cameron Yin; Jianlan Sun; Su Chen; Ramya Muddasani; Gary Lu
Journal:  J Biomed Biotechnol       Date:  2011-01-20

Review 4.  Rare cytogenetic abnormalities in myelodysplastic syndromes.

Authors:  Ulrike Bacher; Julie Schanz; Friederike Braulke; Detlef Haase
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-01       Impact factor: 2.576
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.